Abstract
A forerunning study on the relationship between antibodies to the protective antigen (PA) and lethal factor (LF) components of anthrax toxin and protective immunity has been expanded and extended to include the third toxin component, the edema factor (EF). It was found that protection against the “vaccine resistant” Ames strain was possible in the absence of detectable anti-LF and anti-EF antibodies. Evidence is given that PA may be the essential anthrax-derived antigen for protection, but that equally essential is that it be presented to the host's immune system in such a manner as to provide stimulation of more than just production of antibody to PA. Titers to the three components in sera of individuals with histories of clinically diagnosed anthrax as well as from human vaccinees are included in the report.
Similar content being viewed by others
References
Ivins BE, Ezzell JW, Jemski J, Hedlund KW, Ristroph JD, Leppla SH (1986) Immunization studies with attenuated strains of Bacillus anthracis. Infect Immun 52:454–458
Ivins BE, Welkos SL (1986) Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis. Infect Immun 54:537–542
Leppla SH (1982) Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations in eukaryotic cells. Proc Natl Acad Sci USA 79:3162–3166
Leppla SH (1984) Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eukaryotic cells. Adv Cyclic Nucleotide Protein Phosphorylation Res 17:189–198
Quinn CP, Shone CC, Turnbull PCB, Melling J (1988) Purification of anthrax toxin components by high performance anion exchange, gel-filtration and hydrophobic interaction chromatography. Biochem J 252:753–758
Turnbull PCB (1986) Bacillus cereus toxins. In: Dorner F, Drews J (eds) Pharmacology of bacterial toxins. International Encyclopedia of Pharmacology and Therapeutics, Section 119. Permagon Press, Oxford New York, pp 397–448
Turnbull PCB, Broster MG, Carman JA, Manchee RJ, Melling J (1986) Development of anti-bodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infect Immun 52:356–363
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Turnbull, P.C.B., Leppla, S.H., Broster, M.G. et al. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Med Microbiol Immunol 177, 293–303 (1988). https://doi.org/10.1007/BF00189414
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00189414